Clinical trial
Edaravone and Argatroban Stroke Therapy Study for Acute Ischemic Stroke
NCT00153946 · Combination Therapy for Acute Ischemic Stroke Study Group, Other · Completed
Key facts
| NCT number | NCT00153946 |
|---|---|
| Title | Edaravone and Argatroban Stroke Therapy Study for Acute Ischemic Stroke |
| Official title | Multicenter Randomized Open-Label Comparison Study on the Efficacy and Safety of Argatroban Monotherapy With Argatroban-Edaravone Combination Therapy |
| Acronym | EAST |
| Lead sponsor | Combination Therapy for Acute Ischemic Stroke Study Group, Other |
| Collaborators | Japan Cardiovascular Research Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Stroke |
| Intervention type | Drug |
| Interventions | Edaravone |
| Enrollment | 814 |
| Start date | Aug 1, 2004 |
| Primary completion | Mar 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | May 14, 2008 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: